GlassScriptPhysician profile
Jennifer Randle
NPI 1497857866
$23,633.80
in general payments reported to CMS, 2019-2025
26 companies · $6,159 in 2025
The $6,159 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,003 · 2020: $323 · 2021: $1,006 · 2022: $1,314 · 2023: $7,541 · 2024: $6,287 · 2025: $6,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $3,921 · Travel and Lodging: $3,576 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,472.50 |
| Food and Beverage | $3,921.35 |
| Travel and Lodging | $3,576.14 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $17,106.84 | 2021-2025 | Oxervate |
| Alcon Vision LLC | $1,121.97 | 2019-2025 | Total30, Clareon, Argos |
| Sun Pharmaceutical Industries INC. | $1,086.19 | 2019-2025 | Cequa |
| Allergan, INC. | $836.41 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $641.99 | 2024-2025 | Xdemvy |
| Abbvie INC. | $371.28 | 2022-2025 | |
| Glaukos Corporation | $325.13 | 2022-2025 | Idosetr, Idose |
| Kala Pharmaceuticals, INC. | $310.02 | 2021-2022 | |
| Oyster Point Pharma, INC. | $264.66 | 2022-2024 | Tyrvaya |
| Coopervision INC. | $263.86 | 2019-2023 | Myday Contact Lens |
| Biotissue Holdings INC. | $227.00 | 2021-2025 | |
| Harrow Eye, LLC | $201.69 | 2024-2025 | Vevye, Iheezo |
| Amgen INC. | $124.74 | 2024 | Tepezza |
| Rayner Intraocular Lenses Limited | $117.52 | 2024-2025 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Novartis Pharmaceuticals Corporation | $107.68 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $94.32 | 2019 | |
| Bausch & Lomb Americas INC. | $87.49 | 2022-2025 | Miebo |
| New World Medical,INC. | $84.41 | 2023-2025 | Streamline, Kahook Dual Blade, Via360 |
| Shire North American Group INC | $68.60 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $40.71 | 2019-2025 | Lipiflow System Activator (Disposable) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.29 | 2019-2021 | |
| Maculogix, INC. | $30.00 | 2021 | |
| Rxsight INC | $24.06 | 2022 | |
| Beaver-Visitec International, INC. | $21.28 | 2021 | |
| Sight Sciences, INC. | $20.53 | 2021 | |
| Eyevance Pharmaceuticals LLC | $16.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Randle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.